Cargando…
Coagulation Inhibitors in COVID-19 Leading to Compressive Airway Hematoma
We are focusing on three things for every patient in the hospital with COVID-19, namely dexamethasone, remdesivir and enhanced anticoagulation protocols as this had shown improved mortality. However, the bleeding risk in these patients has not been taken into consideration. In our ICU setting at Roc...
Autor principal: | Mohamed, Amr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797446/ https://www.ncbi.nlm.nih.gov/pubmed/33457144 http://dx.doi.org/10.7759/cureus.12580 |
Ejemplares similares
-
COVID-19 and Subsequent Development of Pancytopenia With Concurrent Disseminated Intravascular Coagulation
por: Dube, Michael D, et al.
Publicado: (2022) -
COVID-19 Pathogen Viral Evolution Leading to Increased Infectivity
por: Parag, Sonam, et al.
Publicado: (2022) -
Purpura Fulminans: A Cutaneous Marker of Disseminated Intravascular Coagulation
por: Ghosh, Sudip Kumar, et al.
Publicado: (2009) -
Isolation of Patients With Bacterial Pneumonia Suspected of COVID-19 Leads to Prolonged Hospitalization
por: Tamura, Akiko, et al.
Publicado: (2022) -
Prolonged Oxygen Therapy Post COVID-19 Infection: Factors Leading to the Risk of Poor Outcome
por: Ray, Alokananda, et al.
Publicado: (2021)